trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Myopathy, Central Core D020512 1 associated lipids
Roseolovirus Infections D019349 1 associated lipids
Chromosome Inversion D007446 1 associated lipids
Thyroid Hormone Resistance Syndrome D018382 1 associated lipids
Rhabdomyosarcoma, Embryonal D018233 1 associated lipids
Gestational Trophoblastic Disease D031901 1 associated lipids
Carcinoma, Papillary, Follicular D018265 1 associated lipids
Visceral Pain D059265 1 associated lipids
Rhabdoid Tumor D018335 1 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Rubinstein-Taybi Syndrome D012415 1 associated lipids
Classical Lissencephalies and Subcortical Band Heterotopias D054221 1 associated lipids
Goldenhar Syndrome D006053 1 associated lipids
Capsule Opacification D058442 1 associated lipids
Adenomyosis D062788 1 associated lipids
Neoplasm Micrometastasis D061206 1 associated lipids
Cystadenoma, Serous D018293 1 associated lipids
Intervertebral Disc Degeneration D055959 1 associated lipids
Supratentorial Neoplasms D015173 1 associated lipids
von Hippel-Lindau Disease D006623 1 associated lipids
Hypesthesia D006987 1 associated lipids
Cystadenocarcinoma, Mucinous D018282 1 associated lipids
Fibromatosis, Aggressive D018222 2 associated lipids
Cystadenocarcinoma, Serous D018284 2 associated lipids
Rhabdomyosarcoma, Alveolar D018232 2 associated lipids
Small Cell Lung Carcinoma D055752 2 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Inflammatory Breast Neoplasms D058922 2 associated lipids
Ganglioneuroma D005729 2 associated lipids
Mastocytoma D034801 3 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Osteomalacia D010018 5 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Genomic Instability D042822 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Enteritis D004751 8 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Retinoblastoma D012175 12 associated lipids
Keloid D007627 12 associated lipids
Cat Diseases D002371 12 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Radiation Injuries D011832 14 associated lipids
Brain Neoplasms D001932 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Leishmaniasis D007896 19 associated lipids
Translocation, Genetic D014178 20 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Hypersensitivity D006967 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Fibrosis D005355 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Breast Neoplasms D001943 24 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Glioblastoma D005909 27 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Yokota T et al. Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. 2004 Oncogene pmid:15107822
Suzuki M et al. Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b. 2006 Oncogene pmid:16331260
McGarry LC et al. Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes. 2004 Oncogene pmid:15107823
Guo WH et al. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. 2002 Oncogene pmid:12447699
Tessema M et al. Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis. 2010 Oncogene pmid:20562917
Vincent A et al. Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells. 2007 Oncogene pmid:17471237
Zhong S et al. Phosphorylation at serine 28 and acetylation at lysine 9 of histone H3 induced by trichostatin A. 2003 Oncogene pmid:12917630
Futamura M et al. Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells. 1995 Oncogene pmid:7700637
Mühlisch J et al. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. 2006 Oncogene pmid:16186793
Cismasiu VB et al. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. 2005 Oncogene pmid:16091750
Sengupta S et al. Tumor suppressor p53 represses transcription of RECQ4 helicase. 2005 Oncogene pmid:15674334
Busson M et al. Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation. 2005 Oncogene pmid:15674337
Shin HJ et al. Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. 2003 Oncogene pmid:12813458
Shteper PJ et al. Role of promoter methylation in regulation of the mammalian heparanase gene. 2003 Oncogene pmid:14586400
Hirose T et al. p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y. 2003 Oncogene pmid:14586402
Zubia A et al. Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity. 2009 Oncogene pmid:19169274
Acun T et al. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas. 2015 OMICS pmid:25831062
Acun T et al. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer. 2017 OMICS pmid:28481734
Aoyama M et al. Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41/GPR-43 pathways. 2010 Nutrition pmid:20004081
Miyoshi M et al. Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells. 2008 Nov-Dec Nutrition pmid:18723323
Usami M et al. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. 2008 Nutr Res pmid:19083427
Cowell IG et al. Histone deacetylase inhibition redistributes topoisomerase IIβ from heterochromatin to euchromatin. 2011 Jan-Feb Nucleus pmid:21647300
Pérez-Garrastachu M et al. Nucleoporins redistribute inside the nucleus after cell cycle arrest induced by histone deacetylases inhibition. 2017 Nucleus pmid:28696859
Kishikawa S et al. Roles of histone acetylation in the Dnmt1 gene expression. 2002 Nucleic Acids Res. Suppl. pmid:12903179
Kishikawa S et al. Control elements of Dnmt1 gene are regulated in cell-cycle dependent manner. 2003 Nucleic Acids Res. Suppl. pmid:14510503
Lefevre P et al. Identification of factors mediating the developmental regulation of the early acting -3.9 kb chicken lysozyme enhancer element. 2001 Nucleic Acids Res. pmid:11713304
Hsu DW et al. Dynamic acetylation of lysine-4-trimethylated histone H3 and H3 variant biology in a simple multicellular eukaryote. 2012 Nucleic Acids Res. pmid:22600736
Hansen KR et al. Evolutionary-conserved telomere-linked helicase genes of fission yeast are repressed by silencing factors, RNAi components and the telomere-binding protein Taz1. 2006 Nucleic Acids Res. pmid:16407326
Ziesché E et al. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. 2013 Nucleic Acids Res. pmid:23087373
Drewell RA et al. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. 2002 Nucleic Acids Res. pmid:11861904
Seuter S et al. Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. 2013 Nucleic Acids Res. pmid:23093607
Yáñez RJ and Porter AC A chromosomal position effect on gene targeting in human cells. 2002 Nucleic Acids Res. pmid:12433992
Diplas AI et al. Demonstration of all-or-none loss of imprinting in mRNA expression in single cells. 2009 Nucleic Acids Res. pmid:19767614
Benjamin D and Jost JP Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. 2001 Nucleic Acids Res. pmid:11522830
Ryu JR and Arnosti DN Functional similarity of Knirps CtBP-dependent and CtBP-independent transcriptional repressor activities. 2003 Nucleic Acids Res. pmid:12888527
Hirschler-Laszkiewicz I et al. The role of acetylation in rDNA transcription. 2001 Nucleic Acids Res. pmid:11600700
Wu Y et al. Acetylation-dependent function of human single-stranded DNA binding protein 1. 2015 Nucleic Acids Res. pmid:26170237
Pinz S et al. Deacetylase inhibitors repress STAT5-mediated transcription by interfering with bromodomain and extra-terminal (BET) protein function. 2015 Nucleic Acids Res. pmid:25769527
Malinen M et al. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. 2008 Nucleic Acids Res. pmid:17999998
Chang LK and Liu ST Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. 2000 Nucleic Acids Res. pmid:11024171
Hayashi-Takanaka Y et al. Tracking epigenetic histone modifications in single cells using Fab-based live endogenous modification labeling. 2011 Nucleic Acids Res. pmid:21576221
Kemp MG et al. The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells. 2005 Nucleic Acids Res. pmid:15653633
Makki MS et al. TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels. 2008 Nucleic Acids Res. pmid:18535006
Allgayer J et al. Widespread transcriptional gene inactivation initiated by a repair intermediate of 8-oxoguanine. 2016 Nucleic Acids Res. pmid:27220469
Khobta A et al. Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region. 2010 Nucleic Acids Res. pmid:20338881
Camarero N et al. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site. 2003 Nucleic Acids Res. pmid:12626711
Valls E et al. The SV40 T antigen modulates CBP histone acetyltransferase activity. 2003 Nucleic Acids Res. pmid:12799439
Ferguson M et al. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. 2003 Nucleic Acids Res. pmid:12799440
Mao DY et al. Promoter-binding and repression of PDGFRB by c-Myc are separable activities. 2004 Nucleic Acids Res. pmid:15226411
Gialitakis M et al. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. 2006 Nucleic Acids Res. pmid:16452299